Provided by Tiger Trade Technology Pte. Ltd.

Organon & Co

13.75
+0.01000.07%
Post-market: 13.73-0.0200-0.15%19:56 EDT
Volume:1.77M
Turnover:24.27M
Market Cap:3.61B
PE:17.34
High:13.76
Open:13.74
Low:13.73
Close:13.74
52wk High:13.76
52wk Low:5.69
Shares:262.60M
Float Shares:243.00M
Volume Ratio:0.63
T/O Rate:0.73%
Dividend:0.08
Dividend Rate:0.58%
EPS(TTM):0.7929
EPS(LYR):0.7200
ROE:24.04%
ROA:5.67%
PB:3.59
PE(LYR):19.10

Loading ...

Organon opens REMS Program for Miudella

TIPRANKS
·
Aug 11

Eikon Therapeutics Appoints Merck’s Johnny Bennett to Scientific Advisory Board

Reuters
·
Aug 10

Organon Head of Mfg & Supply Juliana Drinane Sells 14,761 Shares for $200,506.77

Reuters
·
Aug 06

Organon & Co Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 03

Organon Keeps Quarterly Dividend at $0.02 a Share, Payable Sept. 10 to Holders of Record Aug. 14

MT Newswires Live
·
Jul 31

Organon Declares Quarterly Dividend of $0.02 a Share

Reuters
·
Jul 31

Press Release: Organon Announces Quarterly Dividend

Dow Jones
·
Jul 31

Organon's Vtama Cream for Atopic Dermatitis Showed Improvement in Disease Severity in Clinical Study

MT Newswires Live
·
Jul 24

Organon to present results from analysis of Phase 3 trials of VTAMA cream

TIPRANKS
·
Jul 24

Organon Holds Special Shareholder Meeting on Merger Agreement Proposal

Reuters
·
Jul 24

Organon Canada Announces the Appointment of Dominic Bégin as President and Managing Director

THOMSON REUTERS
·
Jul 22

Press Release: Organon Canada Announces the Appointment of Dominic BÉGIN as President and Managing Director

Dow Jones
·
Jul 22

NYSE Order Imbalance 314683.0 Shares on Buy Side

THOMSON REUTERS
·
Jul 21

Organon & Co - Complaint Filed July 6, 2026 Against Organon Board, Sun Pharma USA, Sun Pharma America- SEC Filing

THOMSON REUTERS
·
Jul 18

Organon & Co: Believes That Claims, Allegations in Complaint & Assertions in Pending Injunction Motion are Without Merit

THOMSON REUTERS
·
Jul 18

Press Release: Organon to Report Second Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing

Dow Jones
·
Jul 16

Organon to Present New Pooled Phase 3 Analysis of VTAMA in Atopic Dermatitis at 2026 Pediatric Dermatology Meeting

Reuters
·
Jul 07

Jefferies Quarterly Profit Misses Estimates as Asset Management Weighs

Reuters
·
Jun 25

Jefferies Quarterly Profit More than Doubles on Dealmaking, Equities Strength

Reuters
·
Jun 25

Organon, Shanghai Henlius Biotech Launch Denosumab Biosimilars in Canada

MT Newswires Live
·
Jun 23